Parvovirus B19 in Idiopathic Thrombocytopenic Purpura
2000; Wiley; Volume: 79; Issue: 2 Linguagem: Inglês
10.1046/j.1423-0410.2000.79201181.x
ISSN1423-0410
AutoresA. Wehmeier, Anna Maria Eis‐Hübinger, Monika Maas Enriquez, Horst Beckmann,
Tópico(s)Platelet Disorders and Treatments
ResumoVox SanguinisVolume 79, Issue 2 p. 118-118 Parvovirus B19 in Idiopathic Thrombocytopenic Purpura Artur Wehmeier, Artur Wehmeier Medical Clinic I, Haematology, Oncology, Nephrology, Klinikum Remscheid, Remscheid, GermanySearch for more papers by this authorAnna Maria Eis-Hübinger, Anna Maria Eis-Hübinger Institute of Medical Microbiology and Immunology, University of Bonn, Bonn, GermanySearch for more papers by this authorMonika Maas Enriquez, Monika Maas Enriquez Bayer Vital GmbH & Co. KG, Leverkusen, GermanySearch for more papers by this authorHorst Beckmann, Horst Beckmann Bayer Vital GmbH & Co. KG, Leverkusen, GermanySearch for more papers by this author Artur Wehmeier, Artur Wehmeier Medical Clinic I, Haematology, Oncology, Nephrology, Klinikum Remscheid, Remscheid, GermanySearch for more papers by this authorAnna Maria Eis-Hübinger, Anna Maria Eis-Hübinger Institute of Medical Microbiology and Immunology, University of Bonn, Bonn, GermanySearch for more papers by this authorMonika Maas Enriquez, Monika Maas Enriquez Bayer Vital GmbH & Co. KG, Leverkusen, GermanySearch for more papers by this authorHorst Beckmann, Horst Beckmann Bayer Vital GmbH & Co. KG, Leverkusen, GermanySearch for more papers by this author First published: 25 March 2003 https://doi.org/10.1046/j.1423-0410.2000.79201181.xCitations: 3 Prof. Dr. Artur Wehmeier, Medizinische Klinik 1, Hämatologie, Onkologie, Nephrologie, Klinikum Remscheid GmbH, Postfach 160 180, D–42830 Remscheid (Germany), Tel. +49 2191 13 3900, Fax +49 2191 13 3909 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Otten A. Bossuyt PMM, Vermeulen M, Brand A: Intravenous immunoglobulin treatment in hematological diseases. Eur J Haematol 1998; 60: 73–85. 10.1111/j.1600-0609.1998.tb01002.x CASPubMedWeb of Science®Google Scholar 2 Lefrère JJ, Couroucé AM, Kaplan C: Parvovirus and idiopathic thrombocytopenic purpura. Lancet 1989; i: 279. 10.1016/S0140-6736(89)91290-7 Google Scholar 3 van Elsacker-Niele AMW, Weiland HT, Kroes ACM, Kappers-Klunne MC: Parvovirus B19 infection and idiopathic thrombocytopenic purpura. Ann Hematol 1996; 72: 141–144. 10.1007/s002770050152 PubMedWeb of Science®Google Scholar 4 Anderson LJ: Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987; 6: 711–718. 10.1097/00006454-198708000-00003 CASPubMedWeb of Science®Google Scholar 5 Cohen BJ, Buckley MM: The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 25: 151–153. 10.1099/00222615-25-2-151 CASPubMedWeb of Science®Google Scholar Citing Literature Volume79, Issue2September 2000Pages 118-118 ReferencesRelatedInformation
Referência(s)